Literature DB >> 14741335

Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats.

Ryuichi Ideta1, Yasuo Yanagi, Yasuhiro Tamaki, Fumitaka Tasaka, Atsushi Harada, Kazunori Kataoka.   

Abstract

Exudative age-related macular degeneration, characterized by choroidal neovascularization (CNV), is a major cause of visual loss. In this study, we examined the distribution of the polyion complex (PIC) micelle encapsulating FITC-P(Lys) in blood and in experimental CNV in rats to investigate whether PIC micelle can be used for treatment of CNV. We demonstrate that PIC micelle has long-circulating characteristics, accumulating to the CNV lesions and is retained in the lesion for as long as 168 h after intravenous administration. These results raise the possibility that PIC micelles can be used for achieving effective drug targeting to CNV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741335     DOI: 10.1016/s0014-5793(03)01315-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Application of ultrasound microbubble contrast technology in ophthalmic targeted therapy: literature analysis.

Authors:  Jia-Ying Yuan; Jian-Hua Zhang; Chong Tang; Hong Zhu; Hua Xie; Shuan-Jie Gao
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

2.  A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.

Authors:  Mark C Butler; Patrick N Itotia; Jack M Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

3.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

4.  siRNA-based therapy ameliorates glomerulonephritis.

Authors:  Hideki Shimizu; Yuichi Hori; Shinya Kaname; Koei Yamada; Nobuhiro Nishiyama; Satoru Matsumoto; Kanjiro Miyata; Makoto Oba; Akira Yamada; Kazunori Kataoka; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

5.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

Review 6.  Recent perspectives on the delivery of biologics to back of the eye.

Authors:  Mary Joseph; Hoang M Trinh; Kishore Cholkar; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2016-09-06       Impact factor: 6.648

Review 7.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.

Authors:  Joanne D Du; Wye-Khay Fong; Suzanne Caliph; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 8.  Controlled ocular drug delivery with nanomicelles.

Authors:  Ravi D Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-02

Review 9.  Biodegradable intraocular therapies for retinal disorders: progress to date.

Authors:  Noriyuki Kuno; Shinobu Fujii
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

10.  Gene transfer using micellar nanovectors inhibits choroidal neovascularization in vivo.

Authors:  Aya Iriyama; Makoto Oba; Takehiko Ishii; Nobuhiro Nishiyama; Kazunori Kataoka; Yasuhiro Tamaki; Yasuo Yanagi
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.